
Last Price
52 Week Range
¥1.36K - ¥1.66K
Next Earnings Date
Jan 30 2026 (Estimate)
Next Earnings Date
Jan 30 2026 (Est.)
Last Price
Market Cap | ¥129.50B |
EV | ¥143.58B |
Shares Outstanding | 78.53M |
Beta | 0.15 |
Industry | Specialty Retail |
Analyst Rating | NO_OPINION |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E 2026E | 15.21x |
P/Revenue 2026E | 0.47x |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2026E | - |
Net Profit Margin 2026E | 3.13% |
ROE 2026E | 6.40% |
ROCE 2025 | 6.24% |
DPS 2026E | ¥60.00 |
Payout Ratio 2026E | 55.33% |
Div. Yield 2026E | 3.66% |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y

Autobacs Seven Co., Ltd.
9832
Sector
Consumer Cyclical
Industry
Specialty Retail
CEO
Horii, Yugo
Employees
5,201
Website
www.autobacs.co.jpIPO Date
2001-01-04
Headquarters
NBF Toyosu Canal Front, 5-6-52, Toyosu, Koto-ku, Tokyo 135-8717, Japan
The last closing price of Autobacs Seven (9832) is ¥1649.00, reflecting a -0.42% change from the prior session. Last updated: January 1, 2026 at 1:34 AM Eastern Time
Review the recent 9832 stock performance trends:Past 1 Month: Autobacs Seven (9832) shares have +1.66%.Past 3 Months: The stock has +2.11%.Past 6 Months: 9832 shares have +14.91%. Last updated: January 1, 2026 at 12:11 AM Eastern Time
Over the last year, Autobacs Seven (9832) has established a 52-week price range between a high of ¥1664.00 and a low of ¥1356.00. This metric is essential for assessing the stock's annual volatility. Last updated: January 1, 2026 at 12:11 AM Eastern Time
Autobacs Seven (9832) is considered a low volatility stock. It has a beta of 0.15, which means it typically moves 0.15 times as much as the broader market. Over the past 52 weeks, 9832 has traded within a ¥1356.00 – ¥1664.00 range. Last updated: January 1, 2026 at 12:11 AM Eastern Time
A ¥1,000 investment in Autobacs Seven 5 years ago, when the stock was trading around ¥1412.13, would be worth approximately ¥1167.74 today, based solely on share price performance (excluding dividends). This represents a total return of 16.77% over the period, equivalent to a compound annual growth rate (CAGR) of 3.15%. Past performance reflects historical price movements only and does not imply future results. Last updated: January 1, 2026 at 12:11 AM Eastern Time
The current Autobacs Seven (9832) market capitalization is approximately ¥129.50B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Autobacs Seven's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:11 AM Eastern Time
In the most recently reported quarter, Autobacs Seven (9832) generated ¥64.62B in revenue, representing a +14.79% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 3:56 AM Eastern Time
In the most recently reported fiscal year, Autobacs Seven (9832) generated net income of ¥8.13B, compared with ¥6.36B in the prior fiscal year, representing a +27.96% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of ¥8.71B. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 3:56 AM Eastern Time
According to its latest quarterly filing, Autobacs Seven (9832) reported EBITDA of ¥4.16B, representing a +44.83% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 3:56 AM Eastern Time
As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.25x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 3:56 AM Eastern Time
Based on the latest available data, Autobacs Seven (9832) is currently trading at a last twelve months (LTM) P/E ratio of 12.93x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 3:56 AM Eastern Time
Autobacs Seven (9832) is currently scheduled to report its next earnings results on January 29, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: January 1, 2026 at 12:11 AM Eastern Time
In the most recently reported quarter, Autobacs Seven (9832) revenue was ¥64.62B. Earnings per share (EPS) for the quarter were ¥19.10. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 3:56 AM Eastern Time
Based on the latest available analyst coverage, Autobacs Seven (9832) currently carries a NO_OPINION consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 3:56 AM Eastern Time
Like other publicly traded stocks, Autobacs Seven (9832) shares are bought and sold on stock exchanges such as TSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Autobacs Seven (9832) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 9832 to your watchlist.
Autobacs Seven trades under the ticker symbol 9832 on the TSE stock exchange. The ticker 9832 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Autobacs Seven (9832) employs approximately 5,201 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: January 1, 2026 at 12:11 AM Eastern Time
Autobacs Seven (9832) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Autobacs Seven (9832) stock peers based on overlapping products, services, and competitive dynamics:Valvoline (VVV)Peter Warren Automotive Holdings (PWR)Halfords Group (HFD)Pan German Universal Motors (2247)K Car (A381970)Vt Holdings (7593)China Harmony Auto Holding (3836)Yellow Hat (9882)Ku Holdings (9856)OneWater Marine (ONEW) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Autobacs Seven.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.